Transaction in Own Shares

Summary by AI BETAClose X

On August 29, 2025, GSK plc, acting through Merrill Lynch International, purchased 252,588 of its own ordinary shares with a nominal value of 31¼ pence each. The shares were bought on the London Stock Exchange at prices ranging from 1,447.00p to 1,461.50p per share, with a volume-weighted average price of 1,454.14p. These shares will be held as treasury shares as part of an existing buyback program initiated on June 4, 2025, through which the company has purchased 26,274,088 ordinary shares. Following this transaction, GSK holds 244,408,471 ordinary shares in treasury, with 4,070,987,625 ordinary shares in issue, excluding treasury shares; the treasury shares represent 6.00 percent of the voting rights.

Disclaimer*

Companies

GSK (GSK)
UK 100

Latest directors dealings